At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clotild® Smart Guidewire System Evaluation in Endovascular Thrombectomy Procedure
In Brief
A clinical study evaluating Clotild® Smart Guidewire System (CSGS) for Stroke. Completed, enrolled 45 participants across 3 sites in 2 countries.
Detailed Summary
The purpose of this First-in-Human study is to evaluate the safety of using the Clotild® system to guide the endovascular thrombectomy (EVT) device to the clot location during EVT for the treatment of an acute ischemic stroke eligible to EVT, whatever the EVT device chosen. A secondary purpose is to assess the clinical performance, defined as the feasibility of measuring clot electrophysiological parameters in vivo during EVT procedures.
Study Details
Timeline
Interventions
Use of Clotild® Smart Guidewire System as neurovascular guidewire